Gaining over 15,000 cases this 2024 and leading with the lowest survival rate for cancer types, lung cancer has been in the forefront of cancer cases in Australia. Biomarkers such ALK, ROS1, PD-L1, and BRAF are used in IHC and molecular laboratory techniques to identify specific types of lung cancer and guide targeted therapy.
Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
Products are for professional/laboratory use only.
LEF-1 and SOX-11 (MRQ-58) and – top IHC performers for your Lymphoma panel.
We are pleased to be launching the next edition of Cell Marque disease of the month. This is a continuation of a series of disease overviews where we will present commonly diagnosed disease groups and the relevant Cell Marque immunohistochemistry antibodies to assist in the disease diagnosis.
Products are for professional/laboratory use only.
Abstract
Leukaemia and lymphoma are haematologic neoplasms that affect members of all age groups. Each year, over 140,000 people in the US are diagnosed with a haematologic malignancy of some kind.